Evidence map›Paper›PMID 41593163›Full record

ArticleScientific reports2026

Optimized gradient of lyophilized platelet-rich plasma in biomimetic 3D-printed triphasic scaffold based on alginate and gelatin for osteochondral tissue engineering.

Faezeh Ghobadi, Maryam Mohammadi, Rooja Kalantarzadeh, Arezoo Ashrafnia Menarbazari, Jila Majidi, Ehsan Lotfi, Shokoufeh Borhan, Yousef Fatahi, Narendra Pal Singh Chauhan, Ghazaleh Salehi and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Faezeh GhobadiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Maryam MohammadiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Rooja KalantarzadehCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Arezoo Ashrafnia MenarbazariCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Jila MajidiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Ehsan LotfiDepartment of Medical Biotechnology, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Shokoufeh BorhanDepartment of Materials, Chemical and Polymer Engineering, Buein Zahra Technical University, Buein Zahra, Qazvin, Iran.
Yousef FatahiNanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Narendra Pal Singh ChauhanDepartment of Chemistry, Faculty of Science, Bhupal Nobles' University, Udaipur, 313001, Rajasthan, India.
Ghazaleh SalehiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. qazalesalehi@gmail.com.ORCID http://orcid.org/0009-0007-7230-0634
Sara SimorghCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. srsimorgh@gmail.com.ORCID http://orcid.org/0000-0001-6246-9531

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study developed a 3D-printed, triphasic (subchondral bone, calcified, and articular cartilage) scaffold using biological macromolecule-based bioinks to support the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs). A subchondral bone layer was formed by blending various concentrations of graphene oxide (GO) (1% and 2% w/w) into an alginate (Alg) and gelatin (Gel) bioink, two natural biopolymers known for their biocompatibility and biodegradability. Following mechanical and biocompatibility assessments, the 1% GO concentration was selected and applied consistently through the subchondral and calcified cartilage layers. In contrast, the gradient of lyophilized platelet-rich plasma (PRP) powder was adjusted to 1%, 2%, and 3% (w/v) to more accurately replicate the characteristics of calcified and articular cartilage. Triphasic scaffolds with different PRP gradients were evaluated for water absorption, biodegradability, rheological behavior, stem cell viability, and chondroinductive activity. The results indicated that 3D-printed triphasic scaffolds containing 1% or 2% PRP exhibited favorable biomechanical properties, with no significant differences between the two concentrations. However, scaffolds with 2% PRP facilitated the attachment, proliferation, and survival of BM-MSCs, as indicated by an increase in the expression of cartilage-related genes and enhanced production of glycosaminoglycan (GAG), as confirmed through real-time PCR and Alcian Blue staining, respectively.

Indexed as

AlginatesGelatinPlatelet-Rich PlasmaPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsAnimalsBiomimetic MaterialsCartilage, ArticularCell DifferentiationCell ProliferationCell SurvivalChondrogenesisFreeze DryingMesenchymal Stem CellsAlginatesGelatinBiomimetic 3D-printed scaffoldLyophilized platelet-rich plasmaOsteochondral tissue engineering

Identifiers

PMID41593163
PMCPMC12905368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.